
Join to View Full Profile
- 200 First St SWRochester, MN 55905 
Dr. Shanshal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Thoracic oncology
 Phase 1 Early Drug development.
Education & Training
 Mayoclinic MD, Phase 1 Drug development , 2022 - 2023 Mayoclinic MD, Phase 1 Drug development , 2022 - 2023
 Texas Tech University Health Sciences Center at LubbockFellowship, Hematology and Medical Oncology, 2014 - 2017 Texas Tech University Health Sciences Center at LubbockFellowship, Hematology and Medical Oncology, 2014 - 2017
 Chicago Medical School/Rosalind Franklin University of Medicine & ScienceResidency, Internal Medicine, 2012 - 2014 Chicago Medical School/Rosalind Franklin University of Medicine & ScienceResidency, Internal Medicine, 2012 - 2014
 Al-Nahrain University School of MedicineClass of 2005 Al-Nahrain University School of MedicineClass of 2005
Certifications & Licensure
 KY State Medical License 2017 - 2026 KY State Medical License 2017 - 2026
 MN State Medical License 2022 - 2026 MN State Medical License 2022 - 2026
 IL State Medical License 2011 - 2014 IL State Medical License 2011 - 2014
 American Board of Internal Medicine Internal Medicine American Board of Internal Medicine Internal Medicine
 American Board of Internal Medicine Hematology American Board of Internal Medicine Hematology
 American Board of Internal Medicine Medical Oncology American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Service of Excellence Custom learning system, 2019
Publications & Presentations
PubMed
- Treatment of an invasive thymoma-like left innominate venous aneurysm using allogeneic pericardium with continuous horizontal mattress sutures: a case report.Chao Duan, Haibo Wu, Fei Xing, Matthias Lang, Apostolos C Agrafiotis
 Journal of Thoracic Disease. 2025-07-31
- 1 citationsCombination of Lurbinectedin and Osimertinib for Treatment of-Mutated Transformed SCLC: A Brief Report.Aditi Singh, Arthi Sridhar, Aastha Poddar, Anastasios Dimou, Kaushal Parikh
 JTO Clinical and Research Reports. 2025-06-01
- 3 citationsEmerging Targeted Therapies in Non-Small-Cell Lung Cancer (NSCLC).Syeda A Mina, Mohamed Shanshal, Konstantinos Leventakos, Kaushal Parikh
 Cancers. 2025-01-22
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









